← Back to Search

Automated Text Message Reminder Condition for Medication Adherence

N/A
Waitlist Available
Led By AM Barrett, MD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing three interventions to see if they can improve adherence to medication regimens in people who have brain injuries.

Eligible Conditions
  • Medication Adherence
  • Stroke
  • Traumatic Brain Injury
  • Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medication Adherence

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Reminder InterventionsExperimental Treatment2 Interventions
Receive daily reminders from Kessler Foundation study personnel on when to take their medication.
Group II: Standard ConditionActive Control1 Intervention
This group will not receive reminders on when to take their medication from Kessler Foundation staff and will receive the usual and standard care.

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
173 Previous Clinical Trials
10,588 Total Patients Enrolled
AM Barrett, MDPrincipal InvestigatorKessler Foundation
2 Previous Clinical Trials
132 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this study still available?

"Information from clinicaltrials.gov suggests that this trial is no longer enrolling patients, having been initially posted in July 2016 and last updated on February 16th 2021. Nevertheless, there are currently 2115 other studies actively recruiting participants."

Answered by AI
Recent research and studies
Brain InjuryJournal
Stroke Survivors Over-estimate Their Medication Self-administration (MSA) Ability, Predicting Memory Loss
Barrett, A. M., Elizabeth E. Galletta, Jun Zhang, Jenny R. Masmela, and Uri S. Adler. 2014. “Stroke Survivors Over-estimate Their Medication Self-administration (MSA) Ability, Predicting Memory Loss”. Brain Injury. Informa UK Limited. doi:10.3109/02699052.2014.915984.
clinicaltrials.govStudy
Improving Medication Self-Administration and Health After Brain Injury
A. M. Barrett, MD 2016. "Improving Medication Self-Administration and Health After Brain Injury". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03885674.
All > Brain Injury
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top